Earlybird Venture Capital — 2024 Investments
11 investments dated 2024 · listed companies and verified rows first · show all
AIPERIA provides AI-based demand forecasting and production planning for highly perishable fresh goods, generating per-store, per-item order and baking recommendations that factor in around 150 external variables like weather and holidays.
AI & Machine LearningRetail TechSaaS
Fabian Frank(Founder)Franz Seubert Dr. Jan Meller(Founder)Jan Meller(Founder)
Co-investorsETF PartnersLBBW Venture Capital GmbH
Argá Medtech is developing a non-thermal cardiac ablation system based on a proprietary Pulsed Field Ablation (PFA) technology using sine wave energy and a proprietary catheter to treat atrial fibrillation and other heart arrhythmias.
HardwareHealthtechMedical Devices
Co-investorsAdvent Life SciencesHigh Tech GruenderfondsHTGFGilde Healthcare
Briefcase offers bookkeeping software that uses multimodal AI to extract, categorize, and reconcile transaction data and to generate month-end journal entries.
Enterprise SoftwareLondon, GB
Reuben Steenkamp(CEO)inJan Stehlík(CTO)in
Co-investorsActivant CapitalEntrepreneur FirstM13TrueSight VenturesTiny Supercomputer Investment Company
Briefcase provides direct indexing solutions for financial advisers and family offices, enabling customized portfolio strategies that align with client values while managing tax efficiency and tracking market benchmarks.
AI & Machine LearningFintechSaaSSydney, AU
Josh Persky(Founder & CEO)inSean Doherty(Chief Technology Officer)in
Co-investorsCarthona CapitalBek VenturesEntrepreneur FirstTiny Supercomputer Investment Company
Ceartas uses AI to scan millions of websites and platforms for leaked content, deepfakes, and impersonator accounts using a customer's likeness, then issues takedowns across DMCA and other legal frameworks.
AI & Machine LearningCreator EconomyCybersecurityDublin, IE
Dan Purcell(Founder)in
Co-investorsAirbridge Equity PartnersInsiders VenturesUpside Ventures
GEMMABio is a biotechnology company developing gene therapies for rare diseases using next-generation AAV technology, with programs spanning motor neuron disorders and skeletal and cardiomyopathies.
BiotechHealthtechPhiladelphia, US
James M. Wilson(Founder)
Co-investorsIKJ CapitalBioluminescence Ventures
Greywolf is a clinical-stage biotech developing antigen modulation therapies, including oral small molecules in Phase 1/2 trials, for people with cancers and autoimmune disorders.
BiotechDigital HealthHealthtechMedical DevicesOxford, GB
Peter Joyce(Co-founder)inTom McCarthy(Co-founder)in
Co-investorsAndera PartnersCanaan PartnersOxford Science EnterprisesPfizer Venture InvestmentsBritish Patient CapitalPfizer Ventures
Keel is an operations platform that lets teams define custom data models and build tailored systems for their workflows, positioned as an alternative to legacy ERP software.
Developer ToolsEnterprise SoftwareSaaS
Benoit Machefer(Founder)inJon Bretman(Founder)Thomas Frew(Founder)Tom Frew(Founder)
Co-investorsLocalGlobe
Neotaste is a mobile app that connects diners with restaurant deals and promotions in their area, featuring discounts like 2-for-1 main courses from partner restaurants.
ConsumerMarketplaces
Hendrik Sander(Founder)in
Co-investorsBurda Principal Investments
Purcell builds gravity-based bulk food dispensers, plastic-free refill cartridges, and inventory management software (Mission Control) that track consumption and automate reordering for grocery retailers' bulk food aisles.
Circular EconomyHardwareRetail Tech
David Conway(Founder)in
Co-investorsKickstart Innovation
DeepTech company based in Zug (Active)
Ludwig Wurlitzer(Founder)Philipp Man(Founder)
Co-investorsNorrsken VCPICUS CAPITALCreandumEurazeoNorrsken AcceleratorRive Private Investment
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





























